Annual CAPEX
$3.33 B
-$1.36 B-29.01%
31 March 2024
Summary:
Takeda Pharmaceutical Company Limited annual capital expenditures is currently $3.33 billion, with the most recent change of -$1.36 billion (-29.01%) on 31 March 2024. During the last 3 years, it has risen by +$1.10 billion (+49.35%). TAK annual CAPEX is now -29.01% below its all-time high of $4.69 billion, reached on 31 March 2023.TAK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$666.19 M
-$217.75 M-24.63%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited quarterly capital expenditures is currently $666.19 million, with the most recent change of -$217.75 million (-24.63%) on 01 September 2024. Over the past year, it has increased by +$279.46 million (+72.26%). TAK quarterly CAPEX is now -80.10% below its all-time high of $3.35 billion, reached on 31 March 2023.TAK Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$2.53 B
+$279.46 M+12.40%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited TTM capital expenditures is currently $2.53 billion, with the most recent change of +$279.46 million (+12.40%) on 01 September 2024. Over the past year, it has dropped by -$3.50 billion (-58.04%). TAK TTM CAPEX is now -58.94% below its all-time high of $6.17 billion, reached on 31 December 2023.TAK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.0% | +72.3% | -58.0% |
| 3 y3 years | +49.4% | +69.5% | +12.7% |
| 5 y5 years | +175.4% | +107.2% | +81.1% |
TAK CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -29.0% | +101.0% | -80.1% | +169.9% | -58.9% | +52.8% |
| 5 y | 5 years | -29.0% | +175.4% | -80.1% | +169.9% | -58.9% | +81.1% |
| alltime | all time | -29.0% | +1264.5% | -80.1% | +651.9% | -58.9% | +2758.4% |
Takeda Pharmaceutical Company Limited CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $666.19 M(-24.6%) | $2.53 B(+12.4%) |
| June 2024 | - | $883.95 M(+72.9%) | $2.25 B(-32.4%) |
| Mar 2024 | $3.33 B(-29.0%) | $511.25 M(+8.5%) | $3.33 B(-46.0%) |
| Dec 2023 | - | $471.32 M(+21.9%) | $6.17 B(+2.2%) |
| Sept 2023 | - | $386.74 M(-80.3%) | $6.04 B(+2.4%) |
| June 2023 | - | $1.96 B(-41.4%) | $5.90 B(+25.6%) |
| Mar 2023 | $4.69 B(+183.2%) | $3.35 B(+888.1%) | $4.69 B(+157.6%) |
| Dec 2022 | - | $338.83 M(+37.3%) | $1.82 B(-3.3%) |
| Sept 2022 | - | $246.87 M(-67.5%) | $1.88 B(-7.2%) |
| June 2022 | - | $759.22 M(+59.3%) | $2.03 B(+22.5%) |
| Mar 2022 | $1.66 B(-25.7%) | $476.49 M(+18.7%) | $1.66 B(-25.3%) |
| Dec 2021 | - | $401.29 M(+2.1%) | $2.22 B(-1.3%) |
| Sept 2021 | - | $392.99 M(+1.7%) | $2.25 B(+0.3%) |
| June 2021 | - | $386.38 M(-62.8%) | $2.24 B(+0.5%) |
| Mar 2021 | $2.23 B(+11.4%) | $1.04 B(+141.5%) | $2.23 B(+25.9%) |
| Dec 2020 | - | $429.95 M(+11.4%) | $1.77 B(-13.7%) |
| Sept 2020 | - | $386.06 M(+2.6%) | $2.05 B(+3.2%) |
| June 2020 | - | $376.15 M(-35.1%) | $1.99 B(-0.7%) |
| Mar 2020 | $2.00 B(+65.6%) | $579.25 M(-18.6%) | $2.00 B(+8.9%) |
| Dec 2019 | - | $711.22 M(+121.2%) | $1.84 B(+31.5%) |
| Sept 2019 | - | $321.57 M(-17.8%) | $1.40 B(+9.5%) |
| June 2019 | - | $391.06 M(-5.8%) | $1.28 B(+5.6%) |
| Mar 2019 | $1.21 B(+4.5%) | $415.29 M(+53.6%) | $1.21 B(+16.4%) |
| Dec 2018 | - | $270.31 M(+34.6%) | $1.04 B(+11.6%) |
| Sept 2018 | - | $200.81 M(-37.9%) | $931.51 M(-24.4%) |
| June 2018 | - | $323.31 M(+32.0%) | $1.23 B(+6.4%) |
| Mar 2018 | $1.16 B(+11.7%) | $244.96 M(+50.8%) | $1.16 B(-9.3%) |
| Dec 2017 | - | $162.44 M(-67.6%) | $1.28 B(-10.3%) |
| Sept 2017 | - | $501.58 M(+101.7%) | $1.42 B(+23.6%) |
| June 2017 | - | $248.65 M(-31.6%) | $1.15 B(+11.1%) |
| Mar 2017 | $1.04 B | $363.43 M(+17.5%) | $1.04 B(+17.8%) |
| Dec 2016 | - | $309.21 M(+34.6%) | $879.64 M(+17.5%) |
| Sept 2016 | - | $229.78 M(+72.1%) | $748.65 M(+5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $133.51 M(-35.5%) | $712.03 M(+0.7%) |
| Mar 2016 | $707.15 M(-28.9%) | $207.15 M(+16.2%) | $707.15 M(-4.9%) |
| Dec 2015 | - | $178.23 M(-7.7%) | $743.76 M(-0.4%) |
| Sept 2015 | - | $193.16 M(+50.2%) | $746.92 M(+2.2%) |
| June 2015 | - | $128.62 M(-47.2%) | $731.16 M(-26.5%) |
| Mar 2015 | $994.18 M(+26.8%) | $243.76 M(+34.4%) | $994.18 M(+1.5%) |
| Dec 2014 | - | $181.38 M(+2.2%) | $979.10 M(+2.9%) |
| Sept 2014 | - | $177.40 M(-54.7%) | $951.59 M(-7.2%) |
| June 2014 | - | $391.63 M(+71.3%) | $1.03 B(+30.8%) |
| Mar 2014 | $783.95 M(-42.3%) | $228.69 M(+48.6%) | $783.95 M(+41.2%) |
| Dec 2013 | - | $153.87 M(-38.8%) | $555.26 M(+38.3%) |
| Sept 2013 | - | $251.58 M(+67.9%) | $401.39 M(+167.9%) |
| June 2013 | - | $149.81 M(+61.4%) | $149.81 M(-89.6%) |
| Mar 2013 | $1.36 B(+50.9%) | - | - |
| Mar 2012 | $900.09 M(-37.6%) | - | - |
| Mar 2011 | $1.44 B(+53.9%) | $92.82 M(-74.2%) | $1.44 B(-14.4%) |
| Dec 2010 | - | $359.14 M(-22.9%) | $1.68 B(+2.7%) |
| Sept 2010 | - | $465.52 M(-11.3%) | $1.64 B(+19.5%) |
| June 2010 | - | $524.57 M(+56.5%) | $1.37 B(+46.5%) |
| Mar 2010 | $937.22 M(+136.1%) | $335.27 M(+6.4%) | $937.22 M(+55.7%) |
| Dec 2009 | - | $314.99 M(+58.8%) | $601.95 M(+109.8%) |
| Sept 2009 | - | $198.35 M(+123.9%) | $286.95 M(+223.9%) |
| June 2009 | - | $88.61 M | $88.61 M |
| Mar 2009 | $396.89 M(+38.7%) | - | - |
| Mar 2008 | $286.23 M(+14.8%) | - | - |
| Mar 2007 | $249.36 M(-12.1%) | - | - |
| Mar 2006 | $283.84 M(-43.2%) | - | - |
| Mar 2005 | $500.11 M(+4.1%) | - | - |
| Mar 2004 | $480.52 M(+74.7%) | - | - |
| Mar 2003 | $275.01 M(-8.5%) | - | - |
| Mar 2002 | $300.56 M(+23.1%) | - | - |
| Mar 2001 | $244.14 M(-23.6%) | - | - |
| Mar 2000 | $319.41 M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual capital expenditures?
- What is the all time high annual CAPEX for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual CAPEX year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly CAPEX year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM capital expenditures?
- What is the all time high TTM CAPEX for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM CAPEX year-on-year change?
What is Takeda Pharmaceutical Company Limited annual capital expenditures?
The current annual CAPEX of TAK is $3.33 B
What is the all time high annual CAPEX for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual capital expenditures is $4.69 B
What is Takeda Pharmaceutical Company Limited annual CAPEX year-on-year change?
Over the past year, TAK annual capital expenditures has changed by -$1.36 B (-29.01%)
What is Takeda Pharmaceutical Company Limited quarterly capital expenditures?
The current quarterly CAPEX of TAK is $666.19 M
What is the all time high quarterly CAPEX for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly capital expenditures is $3.35 B
What is Takeda Pharmaceutical Company Limited quarterly CAPEX year-on-year change?
Over the past year, TAK quarterly capital expenditures has changed by +$279.46 M (+72.26%)
What is Takeda Pharmaceutical Company Limited TTM capital expenditures?
The current TTM CAPEX of TAK is $2.53 B
What is the all time high TTM CAPEX for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM capital expenditures is $6.17 B
What is Takeda Pharmaceutical Company Limited TTM CAPEX year-on-year change?
Over the past year, TAK TTM capital expenditures has changed by -$3.50 B (-58.04%)